Summary: PROSTATE CANCER

Currently on hormone therapy for Prostate Cancer and experiencing rising PSA.

Inclusion:

  • At least 18 years of age
  • Testosterone < 50
  • Hormone therapy for at least 6 months

Exclusionary:

  • Bone Metastases
  • Prior or current Bisphosphonate use
  • Osteomyelitis or Osteonecrosis of the jaw
  • Any other prior malignancy in past 5 years Except Basal Cell

Qualified participants will receive all study-related care at no charge including doctors visits, physical examinations, lab tests, and study drug.

For more information, contact:

AdvanceMed Research
2 Princess Road, Suite J
Lawrenceville, NJ 08648
Telephone: 609-895-0735

Fill out our Volunteer Form to receive information on how to participate in one of our clinical trials.

Current Studies

Overactive Bladder

• Botox for Bladder Incontinence & Frequency

• Is Overactive Bladder a Part of Your Life? 

Nocturia - Waking Up at Night to Urinate 

Women, Overactive Bladder (OAB)

Overactive Bladder with Urgency

 Single Bladder Instillation for OAB

Overactive Bladder No Placebo

Non-invasive Neurostimulator for OAB

Topical Gel for Treatment of OAB

Stress Urinary Incontinence 


Erectile Dysfunction 

Erectile Dysfunction

Erectile Dysfunction 


Low Testosterone   

Low Testosterone 

 Lack of sexual desire


Prostate Problems 

Enlarged Prostate

BPH

BPH


Prostate Cancer 

 Prostate Cancer Treatment

Prostate Cancer requiring Hormone Therapy 

Prevention of Metastatic Disease

Prostate Cancer with Metastatic Disease


Bladder Cancer 

Intravesical Treatment of non-Invasive Bladder Cancer

Recurrent Bladder Cancer after BCG Treatment


Women's Health Issues 

FSD: Women 30 - 65+

• Decreased Sexual Desire  


 Neurological Health Issues 

Parkinson's Disease 

• Parkinson's Disease Movement/Balance


 Peyronie's Disease

• Peyronie's